The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
e-clinical Trials-Global Market Insights and Sales Trends 2025
Synopsis
The global e-clinical Trials market size is expected to reach US$ 799.5 million by 2029, growing at a CAGR of 5.5% from 2023 to 2029. The market is mainly driven by the significant applications of e-clinical Trials in various end use industries. The expanding demands from the Medical Laboratory, Hospital, Pharmaceutical Company and Other, are propelling e-clinical Trials market. Clinical Data Management System(CDMS) Solutions, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Clinical Trial Management System(CTMS) Solutions segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for e-clinical Trials market, driven by demand from China, the second largest economy with some signs of stabilising, the e-clinical Trials market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for e-clinical Trials, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global e-clinical Trials market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global e-clinical Trials market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, e-clinical Trials sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of e-clinical Trials covered in this report include Acceliant, ActiGraph, eClinicalWorks, IntrinsiQ Specialty Solutions, LMK Clinical Research Consulting, Lucidworks, Medrio, Parallel6 and Symphony Clinical Research, etc.
The global e-clinical Trials market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Acceliant
ActiGraph
eClinicalWorks
IntrinsiQ Specialty Solutions
LMK Clinical Research Consulting
Lucidworks
Medrio
Parallel6
Symphony Clinical Research
Perceptive Informatics
EClinical Solutions
Ecrfplus
Clincase
Global e-clinical Trials market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global e-clinical Trials market, Segment by Type:
Clinical Data Management System(CDMS) Solutions
Clinical Trial Management System(CTMS) Solutions
Electronic Clinical Outcomes Assessment(eCOA) Solutions
Randomization and Trial Supply Management(RTSM) Solutions
Other
Global e-clinical Trials market, by Application
Medical Laboratory
Hospital
Pharmaceutical Company
Other
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of e-clinical Trials companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
The global e-clinical Trials market size is expected to reach US$ 799.5 million by 2029, growing at a CAGR of 5.5% from 2023 to 2029. The market is mainly driven by the significant applications of e-clinical Trials in various end use industries. The expanding demands from the Medical Laboratory, Hospital, Pharmaceutical Company and Other, are propelling e-clinical Trials market. Clinical Data Management System(CDMS) Solutions, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Clinical Trial Management System(CTMS) Solutions segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for e-clinical Trials market, driven by demand from China, the second largest economy with some signs of stabilising, the e-clinical Trials market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for e-clinical Trials, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global e-clinical Trials market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global e-clinical Trials market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, e-clinical Trials sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of e-clinical Trials covered in this report include Acceliant, ActiGraph, eClinicalWorks, IntrinsiQ Specialty Solutions, LMK Clinical Research Consulting, Lucidworks, Medrio, Parallel6 and Symphony Clinical Research, etc.
The global e-clinical Trials market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Acceliant
ActiGraph
eClinicalWorks
IntrinsiQ Specialty Solutions
LMK Clinical Research Consulting
Lucidworks
Medrio
Parallel6
Symphony Clinical Research
Perceptive Informatics
EClinical Solutions
Ecrfplus
Clincase
Global e-clinical Trials market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global e-clinical Trials market, Segment by Type:
Clinical Data Management System(CDMS) Solutions
Clinical Trial Management System(CTMS) Solutions
Electronic Clinical Outcomes Assessment(eCOA) Solutions
Randomization and Trial Supply Management(RTSM) Solutions
Other
Global e-clinical Trials market, by Application
Medical Laboratory
Hospital
Pharmaceutical Company
Other
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of e-clinical Trials companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of e-clinical Trials
1.1 e-clinical Trials Market Overview
1.1.1 e-clinical Trials Product Scope
1.1.2 e-clinical Trials Market Status and Outlook
1.2 Global e-clinical Trials Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global e-clinical Trials Market Size by Region (2018-2029)
1.4 Global e-clinical Trials Historic Market Size by Region (2018-2023)
1.5 Global e-clinical Trials Market Size Forecast by Region (2024-2029)
1.6 Key Regions, e-clinical Trials Market Size (2018-2029)
1.6.1 North America e-clinical Trials Market Size (2018-2029)
1.6.2 Europe e-clinical Trials Market Size (2018-2029)
1.6.3 Asia-Pacific e-clinical Trials Market Size (2018-2029)
1.6.4 Latin America e-clinical Trials Market Size (2018-2029)
1.6.5 Middle East & Africa e-clinical Trials Market Size (2018-2029)
2 e-clinical Trials Market by Type
2.1 Introduction
2.1.1 Clinical Data Management System(CDMS) Solutions
2.1.2 Clinical Trial Management System(CTMS) Solutions
2.1.3 Electronic Clinical Outcomes Assessment(eCOA) Solutions
2.1.4 Randomization and Trial Supply Management(RTSM) Solutions
2.1.5 Other
2.2 Global e-clinical Trials Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global e-clinical Trials Historic Market Size by Type (2018-2023)
2.2.2 Global e-clinical Trials Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America e-clinical Trials Revenue Breakdown by Type (2018-2029)
2.3.2 Europe e-clinical Trials Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific e-clinical Trials Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America e-clinical Trials Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa e-clinical Trials Revenue Breakdown by Type (2018-2029)
3 e-clinical Trials Market Overview by Application
3.1 Introduction
3.1.1 Medical Laboratory
3.1.2 Hospital
3.1.3 Pharmaceutical Company
3.1.4 Other
3.2 Global e-clinical Trials Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global e-clinical Trials Historic Market Size by Application (2018-2023)
3.2.2 Global e-clinical Trials Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America e-clinical Trials Revenue Breakdown by Application (2018-2029)
3.3.2 Europe e-clinical Trials Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific e-clinical Trials Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America e-clinical Trials Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa e-clinical Trials Revenue Breakdown by Application (2018-2029)
4 e-clinical Trials Competition Analysis by Players
4.1 Global e-clinical Trials Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in e-clinical Trials as of 2022)
4.3 Date of Key Players Enter into e-clinical Trials Market
4.4 Global Top Players e-clinical Trials Headquarters and Area Served
4.5 Key Players e-clinical Trials Product Solution and Service
4.6 Competitive Status
4.6.1 e-clinical Trials Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Acceliant
5.1.1 Acceliant Profile
5.1.2 Acceliant Main Business
5.1.3 Acceliant e-clinical Trials Products, Services and Solutions
5.1.4 Acceliant e-clinical Trials Revenue (US$ Million) & (2018-2023)
5.1.5 Acceliant Recent Developments
5.2 ActiGraph
5.2.1 ActiGraph Profile
5.2.2 ActiGraph Main Business
5.2.3 ActiGraph e-clinical Trials Products, Services and Solutions
5.2.4 ActiGraph e-clinical Trials Revenue (US$ Million) & (2018-2023)
5.2.5 ActiGraph Recent Developments
5.3 eClinicalWorks
5.3.1 eClinicalWorks Profile
5.3.2 eClinicalWorks Main Business
5.3.3 eClinicalWorks e-clinical Trials Products, Services and Solutions
5.3.4 eClinicalWorks e-clinical Trials Revenue (US$ Million) & (2018-2023)
5.3.5 IntrinsiQ Specialty Solutions Recent Developments
5.4 IntrinsiQ Specialty Solutions
5.4.1 IntrinsiQ Specialty Solutions Profile
5.4.2 IntrinsiQ Specialty Solutions Main Business
5.4.3 IntrinsiQ Specialty Solutions e-clinical Trials Products, Services and Solutions
5.4.4 IntrinsiQ Specialty Solutions e-clinical Trials Revenue (US$ Million) & (2018-2023)
5.4.5 IntrinsiQ Specialty Solutions Recent Developments
5.5 LMK Clinical Research Consulting
5.5.1 LMK Clinical Research Consulting Profile
5.5.2 LMK Clinical Research Consulting Main Business
5.5.3 LMK Clinical Research Consulting e-clinical Trials Products, Services and Solutions
5.5.4 LMK Clinical Research Consulting e-clinical Trials Revenue (US$ Million) & (2018-2023)
5.5.5 LMK Clinical Research Consulting Recent Developments
5.6 Lucidworks
5.6.1 Lucidworks Profile
5.6.2 Lucidworks Main Business
5.6.3 Lucidworks e-clinical Trials Products, Services and Solutions
5.6.4 Lucidworks e-clinical Trials Revenue (US$ Million) & (2018-2023)
5.6.5 Lucidworks Recent Developments
5.7 Medrio
5.7.1 Medrio Profile
5.7.2 Medrio Main Business
5.7.3 Medrio e-clinical Trials Products, Services and Solutions
5.7.4 Medrio e-clinical Trials Revenue (US$ Million) & (2018-2023)
5.7.5 Medrio Recent Developments
5.8 Parallel6
5.8.1 Parallel6 Profile
5.8.2 Parallel6 Main Business
5.8.3 Parallel6 e-clinical Trials Products, Services and Solutions
5.8.4 Parallel6 e-clinical Trials Revenue (US$ Million) & (2018-2023)
5.8.5 Parallel6 Recent Developments
5.9 Symphony Clinical Research
5.9.1 Symphony Clinical Research Profile
5.9.2 Symphony Clinical Research Main Business
5.9.3 Symphony Clinical Research e-clinical Trials Products, Services and Solutions
5.9.4 Symphony Clinical Research e-clinical Trials Revenue (US$ Million) & (2018-2023)
5.9.5 Symphony Clinical Research Recent Developments
5.10 Perceptive Informatics
5.10.1 Perceptive Informatics Profile
5.10.2 Perceptive Informatics Main Business
5.10.3 Perceptive Informatics e-clinical Trials Products, Services and Solutions
5.10.4 Perceptive Informatics e-clinical Trials Revenue (US$ Million) & (2018-2023)
5.10.5 Perceptive Informatics Recent Developments
5.11 EClinical Solutions
5.11.1 EClinical Solutions Profile
5.11.2 EClinical Solutions Main Business
5.11.3 EClinical Solutions e-clinical Trials Products, Services and Solutions
5.11.4 EClinical Solutions e-clinical Trials Revenue (US$ Million) & (2018-2023)
5.11.5 EClinical Solutions Recent Developments
5.12 Ecrfplus
5.12.1 Ecrfplus Profile
5.12.2 Ecrfplus Main Business
5.12.3 Ecrfplus e-clinical Trials Products, Services and Solutions
5.12.4 Ecrfplus e-clinical Trials Revenue (US$ Million) & (2018-2023)
5.12.5 Ecrfplus Recent Developments
5.13 Clincase
5.13.1 Clincase Profile
5.13.2 Clincase Main Business
5.13.3 Clincase e-clinical Trials Products, Services and Solutions
5.13.4 Clincase e-clinical Trials Revenue (US$ Million) & (2018-2023)
5.13.5 Clincase Recent Developments
6 North America
6.1 North America e-clinical Trials Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe e-clinical Trials Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific e-clinical Trials Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America e-clinical Trials Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa e-clinical Trials Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 e-clinical Trials Market Dynamics
11.1 e-clinical Trials Industry Trends
11.2 e-clinical Trials Market Drivers
11.3 e-clinical Trials Market Challenges
11.4 e-clinical Trials Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
